News
Cryoport Acquires Temperature-Controlled Logistics Provider in Australia
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has acquired Critical Transport Solutions Australia Pty...
Clinical Trials
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced the engagement...
News
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine
Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada. The investment...
Drug Research
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc., the leading global provider of advanced delivery technologies, development,...
News
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in two ongoing clinical trials of...
News
SIRO Clinpharm partners with ACROSS Global Alliance; aims to bridge the gap in the pharmaceutical service provider market
SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent...
Drug Research
Anixa Biosciences, OntoChem ink pact to proceed to next stage of development of potential anti-viral therapy for Covid-19
Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that based on Proof of Concept...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read